Catherine Gutierrez, MD, PhD

Department of Medical Oncology, Dana-Farber Cancer Institute
Boston, MA, United States

N/A

Presentation(s):

• (1554196) SF3B1 mutation and ATM deletion co-drive leukemogenesis via centromeric R-loop dysregulation

  Saturday, October 7, 2023
  9:50 AM – 10:00 AM EDT